Back to TLA

Search Results - christopher+cartmell

2 Results

Sort By:

SAGE: A Low-Cost, High-Throughput Disease Agnostic Microfluidic Discovery Engine

This technology relates to a low-cost, high throughput microfluidic platform device which can help identify therapeutic compounds from a known agent, such as tuberculosis. Through a three-chip process, the invention can encapsulate, cultivate, screen and sort bacteria from a host of environmental microbes for bioactive natural products. The platform...

Published: 12/8/2025 | Inventor(s): Christopher Cartmell, John Streicher

Keywords(s):

Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic, Technology Classifications > Research Tools

Barettin Analogs

This invention features a novel barettin analogs, which are designed for the treatment of tuberculosis (TB) and chronic pain. Barettin, a naturally derived marine compound, has shown promising biological activity, and these synthetic analogs are optimized to enhance therapeutic effects while minimizing potential side effects. The innovation aims to...

Published: 6/30/2025 | Inventor(s): Christopher Cartmell, Michael Okine, John Streicher, Caleb Seekins

Keywords(s):

Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Small Molecules